XNYS · Healthcare · Drug Manufacturers - Specialty & Generic
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | Q1 2026 | 0.72 | 0.78 | +8.33% | $2.52B | ✅ Beat | +2.50% | +1.07% | -4.11% |
| 2026-02-18 | Q4 2025 | 1.24 | 1.10 | -11.29% | $2.80B | ❌ Miss | -3.88% | -1.29% | -19.06% |
| 2025-10-29 |
| Q3 2025 |
| 1.06 |
| 1.16 |
| +9.43% |
| $2.68B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-30 | Q2 2025 | 0.95 | 0.91 | -4.21% | $2.53B | ❌ Miss | +4.07% | -9.86% | +16.12% |
| 2025-04-30 | Q1 2025 | 0.85 | 0.61 | -28.24% | $2.26B | ❌ Miss | +0.00% | -11.32% | -14.53% |
| 2024-08-01 | Q2 2024 | 0.88 | 0.98 | +11.36% | $2.40B | ✅ Beat | -7.70% | -10.16% | -0.49% |
| 2024-05-02 | Q1 2024 | 0.72 | 0.59 | -18.06% | $2.15B | ❌ Miss | -3.34% | -14.09% | -21.76% |
| 2024-02-22 | Q4 2023 | 1.02 | 1.15 | +12.75% | $2.41B | ✅ Beat | — | — | — |
Showing last 8 quarters.